Kegg medicus dgroup
| DG01917 | |
| DG番号 | DG01917 |
| 分類 | DGroup |
| 名称 | Receptor tyrosine kinase inhibitor TYPE Target |
| ステム | - |
| 構造式 |  |
| メンバー | DG03162 EGFR inhibitor D01977 Gefitinib (JP18/USAN/INN) DG00711 Erlotinib D07907 Erlotinib (INN) D04023 Erlotinib hydrochloride (JAN/USAN) DG00717 Afatinib D09724 Afatinib (USAN/INN) D09733 Afatinib dimaleate (USAN); Afatinib maleate (JAN) D10766 Osimertinib mesylate (USAN); Osimertinib mesilate (JAN) D10858 Rociletinib (USAN/INN) DG02916 Olmutinib D10859 Olmutinib (USAN/INN) D11115 Olmutinib hydrochloride (USAN) DG01793 Dacomitinib D09883 Dacomitinib (INN) D10514 Dacomitinib (USAN); Dacomitinib hydrate (JAN) D11251 Icotinib DG03205 Lazertinib D11980 Lazertinib (USAN) D12245 Lazertinib mesilate hydrate (JAN) DG03209 Aumolertinib D12258 Aumolertinib (USAN/INN) D12259 Aumolertinib mesylate (USAN) D03455 Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN) D05350 Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN) D10018 Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN) D11894 Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN) D12457 Tuxobertinib (USAN/INN) D12506 Sunvozertinib (USAN/INN) DG03158 HER2 inhibitor DG00715 Lapatinib D08108 Lapatinib (INN) D04024 Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN) DG02303 Neratinib D08950 Neratinib (USAN/INN) D10898 Neratinib maleate DG03240 Tucatinib D11141 Tucatinib (USAN/INN) D12442 Tucatinib ethanolate (JAN) D03257 Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN) D05446 Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN) D09980 Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN) D11529 Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN) D11375 Trastuzumab duocarmazine (USAN/INN) D10446 Margetuximab (USAN/INN) D11560 Trastuzumab and hyaluronidase DG03203 VEGFR inhibitor D03218 Axitinib (JAN/USAN) DG01360 Cediranib D08881 Cediranib (USAN/INN) D08883 Cediranib maleate (JAN/USAN) DG01375 Tivozanib D09683 Tivozanib (USAN/INN) D10190 Tivozanib hydrochloride (USAN) DG03208 FGFR inhibitor D10927 Erdafitinib (JAN/USAN/INN) D11417 Pemigatinib (JAN/USAN/INN) DG03062 Infigratinib D11589 Infigratinib (USAN/INN) D11611 Infigratinib phosphate (USAN) D11725 Futibatinib (JAN/USAN/INN) DG03148 Mobocertinib D12001 Mobocertinib (USAN/INN) D11969 Mobocertinib succinate (JAN) DG00712 Sunitinib D08552 Sunitinib (INN) D06402 Sunitinib malate (JAN/USAN) D05380 Pazopanib hydrochloride (JAN/USAN) D06407 Vandetanib (JAN/USAN/INN) DG00720 Regorafenib D10138 Regorafenib (USAN/INN) D10137 Regorafenib hydrate (JAN) D10229 Masitinib (INN) DG01670 Cabozantinib D10062 Cabozantinib (USAN) D10095 Cabozantinib s-malate (USAN); Cabozantinib malate (JAN) DG01362 Lenvatinib D09919 Lenvatinib (USAN/INN) D09920 Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN) D05029 Midostaurin (JAN/USAN/INN) DG01364 Quizartinib D09955 Quizartinib (USAN/INN) D09956 Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN) DG01948 Gilteritinib D10709 Gilteritinib (USAN/INN) D10800 Gilteritinib fumarate (JAN/USAN) DG02081 Capmatinib D10696 Capmatinib (USAN/INN) D10891 Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN) D11279 Avapritinib (USAN/INN) D11353 Ripretinib (USAN) DG03087 Tepotinib D11717 Tepotinib (USAN/INN) D11073 Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN) DG01262 Motesanib D06678 Motesanib (USAN) D08947 Motesanib diphosphate (USAN); Motesanib phosphate (JAN) DG01357 Varlitinib D09689 Varlitinib (USAN/INN) D09690 Varlitinib tosylate (USAN) DG01361 Crenolanib D10102 Crenolanib (USAN) D10103 Crenolanib besylate (USAN) DG01363 Toceranib D08503 Toceranib (USAN) D08544 Toceranib phosphate (USAN) DG01367 Golvatinib D10224 Golvatinib (USAN) D10465 Golvatinib tartrate (USAN) DG01373 Brivanib D09589 Brivanib (USAN) D08878 Brivanib alaninate (JAN/USAN/INN) DG02966 Rivoceranib D11288 Rivoceranib (USAN/INN) D11289 Rivoceranib mesylate (USAN) DG03015 Nazartinib D11430 Nazartinib (USAN/INN) D11434 Nazartinib mesylate (USAN) DG03045 Sitravatinib D11140 Sitravatinib (USAN/INN) D11541 Sitravatinib malate (USAN) DG03093 Dubermatinib D11732 Dubermatinib (USAN/INN) D11733 Dubermatinib tartrate (USAN) DG03101 Tesevatinib D11772 Tesevatinib (USAN/INN) D11773 Tesevatinib tosylate (USAN) DG03112 Naquotinib D10958 Naquotinib (USAN/INN) D10886 Naquotinib mesylate (USAN); Naquotinib mesilate (JAN) DG03234 Tasurgratinib D12404 Tasurgratinib (INN) D12405 Tasurgratinib succinate (JAN) DG03273 Zanzalintinib D12650 Zanzalintinib (USAN/INN) D12651 Zanzalintinib fumarate (USAN) D03350 Canertinib dihydrochloride (USAN) D04025 Mubritinib (USAN/INN) D04696 Lestaurtinib (USAN/INN) D05399 Pelitinib (USAN/INN) D05819 Semaxanib (USAN/INN) D06005 Tandutinib (USAN/INN) D06285 Vatalanib (USAN/INN) D08907 Dovitinib lactate (USAN); Dovitinib lactate hydrate (JAN) D09618 Foretinib (USAN/INN) D09635 Linifanib (USAN/INN) D09945 Pegdinetanib (USAN/INN) D10173 Tivantinib (JAN/USAN/INN) D10862 Altiratinib (USAN) D11136 Glesatinib (USAN/INN) D11139 Savolitinib (USAN/INN) D11368 Mavelertinib (USAN/INN) D11438 Bemcentinib (USAN/INN) D11461 Derazantinib hydrochloride (USAN) D11737 Fisogatinib (USAN/INN) D12540 Briquilimab (USAN/INN) D12557 Elzovantinib (USAN/INN) D12600 Bezuclastinib (USAN/INN) |
| 上位グループ | Antineoplastic DG01918 Tyrosine kinase inhibitor |
| 注釈1 | - |
| 注釈2 | - |